Literature DB >> 25287707

Update on the use of hydroxyurea therapy in sickle cell disease.

Trisha E Wong1, Amanda M Brandow2, Wendy Lim3, Richard Lottenberg4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25287707      PMCID： PMC4271176          DOI： 10.1182/blood-2014-08-435768

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  59 in total

1.  Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea.

Authors:  L Couronné; P Schneider; M de Montalembert; C Dumesnil; A Lahary; J P Vannier
Journal:  Ann Hematol       Date:  2008-11-01       Impact factor: 3.673

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia.

Authors:  Masanori Hayashi; Agustin Calatroni; Brittany Herzberg; Allison K Ross; Henry E Rice; Courtney Thornburg
Journal:  J Pediatr Hematol Oncol       Date:  2011-10       Impact factor: 1.289

4.  Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.

Authors:  Anthea Greenway; Russell E Ware; Courtney D Thornburg
Journal:  Am J Hematol       Date:  2011-04       Impact factor: 10.047

5.  Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.

Authors:  Marc S Zumberg; Suresh Reddy; Robert L Boyette; Robert J Schwartz; Thomas R Konrad; Richard Lottenberg
Journal:  Am J Hematol       Date:  2005-06       Impact factor: 10.047

6.  The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

7.  Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.

Authors:  A Ferster; C Vermylen; G Cornu; M Buyse; F Corazza; C Devalck; P Fondu; M Toppet; E Sariban
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

8.  Low dose hydroxyurea is effective in reducing the incidence of painful crisis and frequency of blood transfusion in sickle cell anemia patients from eastern India.

Authors:  Dilip K Patel; Ranjeet S Mashon; Siris Patel; Bhabani S Das; Prasanta Purohit; Subasa C Bishwal
Journal:  Hemoglobin       Date:  2012       Impact factor: 0.849

9.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

10.  Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males.

Authors:  Isabelle Berthaut; Geoffroy Guignedoux; Frederique Kirsch-Noir; Vanina de Larouziere; Celia Ravel; Dora Bachir; Frédéric Galactéros; Pierre-Yves Ancel; Jean-Marie Kunstmann; Laurence Levy; Pierre Jouannet; Robert Girot; Jacqueline Mandelbaum
Journal:  Haematologica       Date:  2008-05-27       Impact factor: 9.941
View more
  31 in total

1.  Oral Monomethyl Fumarate Therapy Ameliorates Retinopathy in a Humanized Mouse Model of Sickle Cell Disease.

Authors:  Wanwisa Promsote; Folami Lamoke Powell; Satyam Veean; Menaka Thounaojam; Shanu Markand; Alan Saul; Diana Gutsaeva; Manuela Bartoli; Sylvia B Smith; Vadivel Ganapathy; Pamela M Martin
Journal:  Antioxid Redox Signal       Date:  2016-08-22       Impact factor: 8.401

2.  Potential of Three Ethnomedicinal Plants as Antisickling Agents.

Authors:  Ismaila O Nurain; Clement O Bewaji; Jarrett S Johnson; Robertson D Davenport; Yang Zhang
Journal:  Mol Pharm       Date:  2016-12-05       Impact factor: 4.939

Review 3.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

4.  Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.

Authors:  Arlene Smaldone; Deepa Manwani; Nancy S Green
Journal:  Pediatr Blood Cancer       Date:  2019-04-02       Impact factor: 3.167

5.  Hydroxyurea Treatment and Development of the Rat Cerebellum: Effects on the Neurogenetic Profiles and Settled Patterns of Purkinje Cells and Deep Cerebellar Nuclei Neurons.

Authors:  Joaquín Martí; M C Santa-Cruz; Roger Serra; José P Hervás
Journal:  Neurotox Res       Date:  2016-07-11       Impact factor: 3.911

Review 6.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

Review 7.  Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review.

Authors:  Joep W R Sins; David J Mager; Shyrin C A T Davis; Bart J Biemond; Karin Fijnvandraat
Journal:  Blood Adv       Date:  2017-08-22

8.  HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.

Authors:  Arlene Smaldone; Sally Findley; Deepa Manwani; Haomiao Jia; Nancy S Green
Journal:  J Pediatr       Date:  2018-03-20       Impact factor: 4.406

Review 9.  Novel insights in the management of sickle cell disease in childhood.

Authors:  Lorenzo Iughetti; Elena Bigi; Donatella Venturelli
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 10.  Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.

Authors:  Winfred C Wang
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.